As a component of the benzamidoxime prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively (By similarity).
Neve, Köfeler, Hendriks, Nordling, Gogvadze, Mkrtchian, Näslund, Ingelman-Sundberg: "Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran." in: PLoS ONE, Vol. 10, Issue 9, pp. e0138487, (2015) (PubMed).
Jakobs, Mikula, Havemeyer, Strzalkowska, Borowa-Chmielak, Dzwonek, Gajewska, Hennig, Ostrowski, Clement: "The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice." in: PloS one, Vol. 9, Issue 8, pp. e105371, (2014) (PubMed).
Thinon, Serwa, Broncel, Brannigan, Brassat, Wright, Heal, Wilkinson, Mann, Tate: "Global profiling of co- and post-translationally N-myristoylated proteomes in human cells." in: Nature communications, Vol. 5, pp. 4919, (2014) (PubMed).
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: "Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells." in: Nature methods, Vol. 10, Issue 4, pp. 315-23, (2013) (PubMed).